Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy
John T. Wei(University of Michigan), Daniel W. Lin(University of Washington), Samson W. Fine(Memorial Sloan Kettering Cancer Center), Fergus V. Coakley(Oregon Health & Science University), Kelvin A. Moses(Bristol-Myers Squibb (Germany)), Merel G. Nissenberg(National Coalition for Cancer Survivorship), Scott E. Eggener(University of California, Los Angeles), Ruth Etzioni(Fred Hutch Cancer Center), Badrinath R. Konety(Allina Health), Martin Miner(Providence College), Simpa S. Salami(University of Michigan), Peter A. Pinto(National Institutes of Health), Erin Kirkby(American Urological Association), Sigrid Carlsson(Memorial Sloan Kettering Cancer Center), Sennett K. Kim(American Urological Association), Lesley Souter(Smiths Detection (Canada)), Misop Han(Johns Hopkins University), Daniel A. Barocas(Vanderbilt University Medical Center), Ian M. Thompson(The University of Texas at San Antonio Health Science Center)
Cited by 177
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
|European Urology|2023|758